Registration for a live webinar on 'Chronic inflammation, immune cell trafficking and anti-trafficking agents' is now open.See webinar details
Dr. Peter Welch Research and Development, Invitrogen Corporation, USA1 Talk
Peter Welch is a Director of R&D at Invitrogen and leads the gene regulation team responsible for RNAi products and services. He received his PhD from the University of California at San Diego, studying the mechanics of the mammalian cell cycle, followed by a postdoctoral position at the same institution.... read morePeter spent 5 years as a scientist at a ribozyme therapeutics company, Immusol Inc., before joining Invitrogen in 1999. His current work focuses on optimizing novel RNAi technologies to bring to market for the research and drug discovery communities. His lab has expertise in both synthetic and vector-based RNAi approaches, as well as lipid and viral delivery for both in vitro and in vivo model systems.